Skip navigation

In this issue...

Innovation – the centre of corporate strategiese
Lord Sainsbury, UK Minister for Science and Innovation
British Innovations
On the road again
Christopher Macgowan, Chief Executive, Society of Motor Manufacturers and Traders
Fossil Fuels – An Energy source for the Future
Greg Lewin, President, Shell Global Solutions
Chain of success
Kenny McKay, Director, and Will Wright, Manager, Restructuring practice at KPMG
Innovation and the Patent Office
Lawrence Smith-Higgins, Head of Awareness Information & Media The UK Patent Office
Benefits of association
Dr Michael Moore, CEO, PIramed Ltd
Innovation and strength in the UK biotech sector
Aisling Burnand, Chief Executive, BioIndustry Association
Simfonec: Helping make good research BIG business
Heron Evidence Development: Successful deal of missed opportunity
Springwell Ltd: Match-maker for Innovative Technologies
Korn/Ferry International: Pharmaceutical companies desire to break the mould
A quality core interface
Dominique Kleyn head of BioPharma Business Development, Imperial College London
Evolutec Group: Creating a range of commercial options
Moving forward
Dr Ceri Williams, Senior Manager, Science and Innovation at Yorkshire Forward and Dr Danielle Hankin, Bioscience Cluster Manager
Oxitech: Revolutionising SIT Programmes
Oxford Expression Technologies: Meeting the needs of the post-genomic era
Business Services
Innovating business related services
Norma Rose, Director-General, Business Services Association
BT: Innovation Strategy and Innovation Continuum
UK Film Council: How the UK wins in the international film industry?
On the defence
Major General Alan Sharman CBE, Director General, Defence Manufacturers Association
ProEtch: Precision parts of quality
Wallop Defence Systems: Aircraft Countermeasures and the Dual Spectral Threat
Education, Education, Education
Ruth Kelly, Secretary of State for Education and Skills
Applied Sciences at Wolverhampton - Innovation in Higher Education Professor Trevor Hocking, Associate Dean, International Development
Wind energy
Marus Rand, Chief Executive, British Wind Energy Association
Vital energy
Ian Leitch, Commercial Director, Energy Industries Council
Waterman Group: Solutions to solve climate control legislation
Winning the war against germs
Dr Ron Mitchell, Managing Director, GB Environmental
Show me the money! Funding for innovation – who can help?
UK: Innovation Nation?
Launching the “Innovation Nation?” initiative
Innovation in the 21st Century
Gemma Harman, Director of Strategy & Media, BT Chief Technology Office
UK Manufacturing - a driving force for innovation
Andrew Manly, Director General, Manufacturing Technologies Association
Waterman Group: Single project model 3D
Renishaw: Achieving global manufacturing competitiveness in the UK
Yorkshire Forward
The European Nanotechnology Trade Alliance
Del Stark, Chief Executive, European Nanotechnology Trade Alliance
University research drives a new wave of innovation
Omar Cheema, Nanotechnology Business Development, Imperial College London
Oxford Instruments: Enabling nanoscience and nanotechnology
Semefab (Scotland): A real driver of change
Metal Nanopowders: New products that meet your needs
Regional Development
London Development Agency: One jump ahead
91Advantage West Midlands: At the heart of it all 95


Revolutionising SIT Programmes

The control of pest insects using chemical insecticides is under pressure to change to environmentally friendly methods. Oxitec might just have the answer.

Oxitec is a dynamic and rapidly growing company, developing novel environmentally friendly methods for the control of pest insects of medical, veterinary and agricultural importance.

Oxitec?s breakthrough proprietary technology, coupled with its global vision for commercialisation, will allow the company to position itself as a leading provider of cost-effective insect pest control through revolutionising an existing biological control method known as the sterile insect technique (SIT).

The $8 billion market for the control of pest insects in agriculture and public health is under increasing pressure to reduce the use of chemical insecticides, and instead to seek more environmentally friendly alternatives. One such approach is SIT, in which factoryreared insects are sterilised with radiation and released to mate with the pest target: since there are then no offspring, the pest population crashes. For some major pests SIT has completely displaced other control methods; for example, it is now the only method used to control Medfly and screwworm in the US and Central America. However, SIT is currently constrained by the use of radiation as a means of sterilising insects. Radiation causes unwanted damage to the released insects, rendering them less effective, and for some species, such as mosquitoes, radiation is too damaging for use.

Oxitec’s vision is to become the leading commercial provider of cost-effective SIT programmes worldwide

Oxitec?s patented technology (RIDLTM ) promises to revolutionise SIT programmes by making it unnecessary to irradiate the insects, and enabling the production of male-only populations. These advances will make SIT much more cost effective, driving further growth and profitability in existing programmes, and opening up major new markets. Oxitec?s vision is to become the leading commercial provider of cost-effective SIT programmes world wide.

The early target markets for Oxitec are:

To realise its vision, Oxitec is pursuing three parallel commercialisation strategies:

  1. Licensing its technology into existing programmes: the company is developing strains of insects for most existing SIT applications.
  2. Vertical integration through acquiring mass-rearing and field programme provision. This will be conducted in collaboration with government programmes, research organisations, large growers or growers? organisations to develop new uses.
  3. Establishing joint ventures to add critical mass to its operations outside Europe.

Enquiries are invited from potential collaborators or venture partners.

Oxitec Limited
71 Milton Park
Oxford OX14 4RX, UK
Tel: +44 (0) 1235 832393